跳转至内容
Merck
CN

03-0208-00

SMC® Human PD-L1 High Sensitivity Immunoassay Kit

Used for ultrasensitive quantification of Human PD-L1 in human serum and plasma

别名:

PD-L1 ultra-sensitive immunoassay, PD-L1 immunoassay kit, Programmed cell death protein ligand 1 kit, PD-L1 kit, Single Molecule Counting, SMC, SMC®, PD-L1, Human PD-L1, Hu PD-L1, checkpoint protein PD-L1, Immuno-oncology PD-L1, PD-L1 Single Molecule Counting kit

登录 查看组织和合同定价。

选择尺寸


关于此项目

NACRES:
NA.51
UNSPSC Code:
12161503
Species reactivity:
human
Technique(s):
single molecule counting: suitable
Usage:
 kit sufficient for 96 wells
Compatibility:
for use with FemtoQuest and SMCxPRO® instruments
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

species reactivity

human

Quality Level

technique(s)

single molecule counting: suitable

input

plasma (K2 EDTA)
serum

UniProt accession no.

compatibility

for use with FemtoQuest and SMCxPRO® instruments

shipped in

wet ice

storage temp.

2-8°C

product line

SMC®

usage

 kit sufficient for 96 wells

General description

Programmed cell death protein ligand 1 (PD-L1), also known as cluster of differentiation 274 (CD274) and B7-H1, is a type 1 membrane protein of 290 amino acids. It is found in a variety of cell types and binds programmed cell death protein (PD-1). It has been indicated as playing a role in autoimmune disease, allograft responses, pregnancy, and other disease states. When PD-L1 binds to PD-1, an inhibitory signal is transmitted that ultimately reduces the proliferation of antigen-specific T cells and reduces the rate of apoptosis in regulatory T-cells. By doing so, PD-L1 contributes to the immune evasion of cancer tissues by suppressing the adaptive immune system. Blocking this activity is thought to restore anti-tumor activity. High PD-L1 expression is correlated with poor prognosis with some cancer types. High levels of the soluble form are also associated with poor prognosis and advanced tumor progression. Multiple PD-L1 inhibiting monoclonal antibodies have been approved as cancer therapeutics.

Application

Immuno-Oncology

Features and Benefits

  • Unlock Hidden Insights in Cancer Immunology: Detect soluble PD-L1 levels associated with tumor progression and poor prognosis, even at sub-picogram concentrations.
  • Accelerate Biomarker Discovery: Ideal for studying immune checkpoint dynamics in cancer, autoimmune disease, and transplant biology.
  • Confidence in Every Data Point: High recovery rates and linearity ensure data integrity across sample types. SMC® T
  • Technology: Digitally detects PD-L1 at ultrasensitive levels—down to 780 fg/mL, ideal for low-expression biomarker studies.

Packaging

96 well assay

Analysis Note

  • Sensitivity: LLOQ 780 fg/mL* (SMCxPRO® Instrument)
  • Standard Curve Range: 390-400,000 fg/mL
  • Intra-assay CV: <15%
  • Inter-assay CV: <20%
  • Linearity: Serum: 120% Plasma: 110%
  • Recovery: Serum: 117% Plasma: 109%
*Indicative LLOQ created from average of 14 independent in house runs, where >80% met same value defined with CV & Recovery +/- 20%. Refer to CoA for lot specific performance.

Other Notes

Although PD-L1 was detectable in rat, mouse, monkey, and canine samples, the assay has not been verified for these species.

Legal Information

FEMTOQUEST is a trademark of Merck KGaA, Darmstadt, Germany
SMC is a registered trademark of Singulex
SMCxPRO is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

pictograms

Health hazardExclamation mark

signalword

Danger

target_organs

Respiratory Tract

存储类别

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - ED ENV 1 - Eye Irrit. 2 - Repr. 1B - STOT RE 2 Inhalation

法规信息

新产品
此项目有

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

相关内容

Explore how to select the best immunoassay platform for your research by choosing between multiplex and singleplex biomarker detection assays, immunoassay instrument platforms, immunoassay software, and services.

Use the power of high sensitivity immunology assays with SMC® technology to precisely characterize low-abundant cytokines like those from Th1/Th2 and Th17 cells.

Explore ultrasensitive immunoassay technology with SMC® technology, including its biomarker detection platform, advantages of high sensitivity assays, and more.

Discover cancer research resources with modeling and profiling tools for cell culture, genomics, biomarkers, and more to help maximize your cancer research.

查看所有结果

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持